BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25671832)

  • 1. Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients.
    Attallah AM; El-Far M; Abdel Malak CA; Omran MM; Farid K; Hussien MA; Albannan MS; Attallah AA; Elbendary MS; Elbesh DA; Elmenier NA; Abdallah MO
    Ann Hepatol; 2015; 14(2):225-33. PubMed ID: 25671832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
    Toson EA; Shiha GE; Abdelgaleel AE
    Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C.
    de Oliveira AC; El-Bacha I; Vianna MV; Parise ER
    Ann Hepatol; 2016; 15(3):326-32. PubMed ID: 27049486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients.
    Attallah AM; El-Far M; Omran MM; Farid K; Albannan MS; El-Dosoky I
    J Clin Lab Anal; 2013 Mar; 27(2):121-9. PubMed ID: 23460258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C.
    Borsoi Viana MS; Takei K; Collarile Yamaguti DC; Guz B; Strauss E
    Ann Hepatol; 2009; 8(1):26-31. PubMed ID: 19221530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.
    Derbala M; Elbadri ME; Amer AM; AlKaabi S; Sultan KH; Kamel YM; Elsayed EH; Avades TY; Chandra P; Shebl FM
    World J Gastroenterol; 2015 Dec; 21(46):13132-9. PubMed ID: 26674154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.
    Fouad R; Elbaz T; Abdel Alem S; Elsharkawy A; Negm M; Khairy M; Hassany M; Cordie A; El Akel W; Esmat G
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):882-887. PubMed ID: 29727382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia.
    Yang LY; Fu J; Peng XF; Pang SY; Gao KK; Chen ZR; He LJ; Wen Z; Wang H; Li L; Wang FH; Yu JK; Xu Y; Gong ST; Xia HM; Liu HY
    World J Gastroenterol; 2015 May; 21(19):5893-900. PubMed ID: 26019453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography.
    Mushtaq S; Ghani E; Azam K; Hussain T
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):357-362. PubMed ID: 30431458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores: How Much Do Routine Blood Tests Tell About Liver Fibrosis in Chronic Hepatitis C?
    Thandassery RB; Al Kaabi S; Soofi ME; Mohiuddin SA; John AK; Al Mohannadi M; Al Ejji K; Yakoob R; Derbala MF; Wani H; Sharma M; Al Dweik N; Butt MT; Kamel YM; Sultan K; Pasic F; Singh R
    J Clin Gastroenterol; 2016 Jul; 50(6):518-23. PubMed ID: 26974762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C.
    Petersen JR; Stevenson HL; Kasturi KS; Naniwadekar A; Parkes J; Cross R; Rosenberg WM; Xiao SY; Snyder N
    J Clin Gastroenterol; 2014 Apr; 48(4):370-6. PubMed ID: 24045284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.